Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martine De Champvallins

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of Hypertension|June 28, 2019
Efficacy of a new single-pill combination of a thiazide-like diuretic and a calcium channel blocker (indapamide sustained release/amlodipine) in essential hypertensionAnna F Dominiczak, Martine de Champvallins, Romualda Brzozowska-Villatte, et al.
Journal of Hypertension|March 6, 2020
ReplyJirar Topouchian, Jean-Jacques Mourad, Martine De Champvallins, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2019
Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research DatalinkKarine Marinier, Pauline Macouillard, Martine de Champvallins, et al.
Journal of Hypertension|July 26, 2019
Feasibility of 24-h central blood pressure monitoring: experience from multinational clinical trial assessing the efficacy of perindopril/indapamide/amlodipineJirar Topouchian, Jean-Jacques Mourad, Martine De Champvallins, et al.
Journal of Hypertension|March 18, 2017
Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trialJean-Jacques Mourad, Celso Amodeo, Martine de Champvallins, et al.
Journal of Hypertension|January 12, 2023
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trialsJohn Chalmers, Jean-Jacques Mourad, Romualda Brzozowska-Villatte, et al.
Advances in Therapy|February 25, 2021
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational StudiesCsaba Farsang, Csaba Andras Dézsi, Romualda Brzozowska-Villatte, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of Hypertension|June 28, 2019
Efficacy of a new single-pill combination of a thiazide-like diuretic and a calcium channel blocker (indapamide sustained release/amlodipine) in essential hypertensionAnna F Dominiczak, Martine de Champvallins, Romualda Brzozowska-Villatte, et al.
Journal of Hypertension|March 6, 2020
ReplyJirar Topouchian, Jean-Jacques Mourad, Martine De Champvallins, et al.
Pharmacoepidemiology and Drug Safety|September 5, 2019
Effectiveness of two-drug therapy versus monotherapy as initial regimen in hypertension: A propensity score-matched cohort study in the UK Clinical Practice Research DatalinkKarine Marinier, Pauline Macouillard, Martine de Champvallins, et al.
Journal of Hypertension|July 26, 2019
Feasibility of 24-h central blood pressure monitoring: experience from multinational clinical trial assessing the efficacy of perindopril/indapamide/amlodipineJirar Topouchian, Jean-Jacques Mourad, Martine De Champvallins, et al.
Journal of Hypertension|March 18, 2017
Blood pressure-lowering efficacy and safety of perindopril/indapamide/amlodipine single-pill combination in patients with uncontrolled essential hypertension: a multicenter, randomized, double-blind, controlled trialJean-Jacques Mourad, Celso Amodeo, Martine de Champvallins, et al.
Journal of Hypertension|January 12, 2023
Benefit of treatment based on indapamide mostly combined with perindopril on mortality and cardiovascular outcomes: a pooled analysis of four trialsJohn Chalmers, Jean-Jacques Mourad, Romualda Brzozowska-Villatte, et al.
Advances in Therapy|February 25, 2021
Beneficial Effects of a Perindopril/Indapamide Single-Pill Combination in Hypertensive Patients with Diabetes and/or Obesity or Metabolic Syndrome: A Post Hoc Pooled Analysis of Four Observational StudiesCsaba Farsang, Csaba Andras Dézsi, Romualda Brzozowska-Villatte, et al.
Pageof 1